Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification
Abstract Background An important mechanism that promoter methylation-mediated gene silencing for gene inactivation is identified in human tumorigenesis. Methylated genes have been found in breast cancer (BC) and beneficial biomarkers for early diagnosis. Prognostic assessment of breast cancer remain...
Main Authors: | Zhao Liu, Jiaxin Liu, Ruimiao Liu, Man Xue, Weifan Zhang, Xinhui Zhao, Jiang Zhu, Peng Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08112-z |
Similar Items
-
Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma
by: Wenxia Meng, et al.
Published: (2019-01-01) -
Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer
by: Qin J, et al.
Published: (2015-12-01) -
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
by: Hege Marie Vedeld, et al.
Published: (2018-05-01) -
Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
by: Wuping Yang, et al.
Published: (2021-03-01) -
Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (ZNF671) Predicts Poor Prognosis in Multiple Solid Tumors
by: Jian Zhang, et al.
Published: (2019-05-01)